Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
08/2003
08/19/2003US6608179 Antibodies, that bind to HIV-2 transmembrane glycoprotein homodimer (gp 80)
08/19/2003US6608177 Mutation of serine replaced with cysteine; use as anti-HIV, anti-allergic or anti- inflammatory agents
08/19/2003US6608108 Method for treatment of tumors using nordihydroguaiaretic acid derivatives
08/19/2003US6608106 Contacting the cell with an amount of dehydroascorbic acid effective to increase the concentration of ascorbic acid in the cell
08/19/2003US6608105 For therapy and prophylaxis of diseases such as cachexia attributed to cancer or infections, rheumatoid arthritis, inflammatory diseases, osteoarthritis, systemic lupus erythematosus, rejection during bone marrow transplantation
08/19/2003US6608104 Gem substituted hydroxamic acids
08/19/2003US6608102 Urinary tract infections caused by P-type Escherichia coli
08/19/2003US6608100 HIV protease inhibitors based on amino acid derivatives
08/19/2003US6608099 Indole sPLA2 inhibitors
08/19/2003US6608087 Gyrase inhibitors and uses thereof
08/19/2003US6608081 Treating pneumonia
08/19/2003US6608078 Antibacterial chiral 8-(substituted piperidino)-benzo [i,j] quinolizines, processes, compositions and methods of treatment
08/19/2003US6608077 Il-8 receptor antagonists
08/19/2003US6608069 Phenyl xanthine derivatives
08/19/2003US6608067 Inhibitors of serine proteases, particularly HCV NS3 protease
08/19/2003US6608066 Tissue factor antagonists and methods of use thereof
08/19/2003US6608058 6-methylnicotinamide derivatives as antiviral agents
08/19/2003US6608046 β-lactamase and DD-peptidase inhibitors
08/19/2003US6608044 Inhibition of TNF activity
08/19/2003US6608036 Oligonucleotide N3′→P5′ thiophosphoramidates: their synthesis and administration to treat neoplasms
08/19/2003US6608035 Orally administering to mammal oligonucleotide of 15 to 30 nucleotides, comprising phosphorothioate linkages between nucleosides and 2'-O-alkoxyalkyl-ribonucleotides at each end, whereby oligonucleotide is intact in liver and kidney tissue
08/19/2003US6608034 Immunovectors for the intracellular and intranuclear transport
08/19/2003US6607882 Regulation of endogenous gene expression in cells using zinc finger proteins
08/19/2003US6607757 At least 13% glucoside isoflavones and 0.6-1.5 parts 3 soya saponins per 1 part by weight of glucoside isoflavones; treating pre or post menopausal symptoms, breast and prostate cancer, and alcoholism
08/19/2003US6607753 Converting extract of Tribulus furostanol saponin compounds to spirostanol compounds; hydrolysis, separation; topical application
08/19/2003US6607730 Chlamydia antigens and corresponding DNA fragments and uses thereof
08/19/2003US6607729 Surface antigen
08/19/2003US6607728 Compounds and methods for the diagnosis and treatment of ehrlichia infection
08/19/2003US6607727 Peptides for inducing cytotoxic T lymphocyte responses to hepatitus B virus
08/19/2003US6607725 Conjugate vaccine for nontypeable Haemophilus influenzae
08/19/2003CA2122613C Targeted delivery of virus vector to mammalian cells
08/19/2003CA2112225C Attenuated revertant serotype 1 marek's disease vaccine
08/19/2003CA2111083C Novel peptides, their preparation and use
08/19/2003CA2095854C Mycobacterium vaccae in the treatment of uveitis
08/19/2003CA2059693C Polysaccharide antigens from streptococcus pneumoniae
08/19/2003CA2012414C Hog cholera virus vaccine and diagnostic
08/14/2003WO2003067221A2 Compositions and methods for restoring immune responsiveness in patients with immunological defects
08/14/2003WO2003067209A2 Ligands to enhance cellular uptake of biomolecules
08/14/2003WO2003066881A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/14/2003WO2003066845A2 Bacteriophage lysin
08/14/2003WO2003066841A1 Viral variants with altered susceptibility to nucleoside analogs and uses thereof
08/14/2003WO2003066824A2 Albumin-fused kunitz domain peptides
08/14/2003WO2003066822A2 Truncated aggrecanase molecules
08/14/2003WO2003066810A2 Recombinant bovine immunodeficiency virus based gene transfer system
08/14/2003WO2003066807A2 Method of inhibiting pathogenicity of infectious agents
08/14/2003WO2003066806A2 Therapeutic use of aziridino compounds
08/14/2003WO2003066649A1 Immunostimulatory, covalently lipidated oligonucleotides
08/14/2003WO2003066636A1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
08/14/2003WO2003066631A1 Antimicrobial thiadiazinone derivatives useful in treatment of bacterial infections
08/14/2003WO2003066630A2 Quinolinone derivatives for treating cell proliferation related disorders
08/14/2003WO2003066621A1 Piperidine derivatives and their use as antagonists of tachykinins
08/14/2003WO2003066618A1 Cytoprotective benzofuran derivatives
08/14/2003WO2003066594A2 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6
08/14/2003WO2003066593A2 Preparation of pharmaceutical salts of 4 ( (z) - (4-bromophenyl) (ethoxyimino) methyl )-1'-( (2,4-dimethyl-1-oxido-3-pyridinyl) carbonyl) -4'-methyl-1,4' bipiperidine as ccr5-antagonists for the treatment of aids and related hiv infections
08/14/2003WO2003066591A1 Piperidine derivative compounds and drugs containing the compounds as the active ingredient
08/14/2003WO2003066590A1 Piperidine derivative compounds and drugs containing the compounds as the active ingredient
08/14/2003WO2003066586A2 Purine and isosteric antibacterial compounds
08/14/2003WO2003066577A1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists
08/14/2003WO2003066103A1 Pharmaceutical compositions for hepatitis c viral protease inhibitors
08/14/2003WO2003066101A1 Preparation for oxidation-sensitive compounds and method for making same
08/14/2003WO2003066094A2 Hepatitis b vaccines
08/14/2003WO2003066093A1 A continuous cell line for the production of vaccines
08/14/2003WO2003066091A2 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations employing tirc7
08/14/2003WO2003066090A1 Immunogenic formulations of variable peptidic epitopes and process for preparation thereof
08/14/2003WO2003066085A1 Albumin-fused anti-angiogenesis peptides
08/14/2003WO2003066084A1 Use of glp-1 compound for treatment of critically ill patients
08/14/2003WO2003066078A1 Hiv inhibiting proteins
08/14/2003WO2003066077A2 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1)
08/14/2003WO2003066065A1 Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds
08/14/2003WO2003066064A2 Methods of resistant bacterial disease treatment using metal-complexed tetracycline antibiotics
08/14/2003WO2003066047A1 Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases
08/14/2003WO2003066030A2 Pharmaceutical tablet
08/14/2003WO2003066021A2 Drug nanoparticles with lysozyme surface stabiliser
08/14/2003WO2003066005A2 Ansamycins having improved pharmacological and biological properties
08/14/2003WO2003066003A2 Anti-pathogen treatements
08/14/2003WO2003066001A2 Zinc salt compositions for the prevention of mucosal irritation from spermicides and microbicides
08/14/2003WO2003065991A2 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
08/14/2003WO2003065988A2 A combination for treating cold and cough
08/14/2003WO2003065987A2 Granzyme b inhibitors
08/14/2003WO2003065980A2 Methods and formulations for eradicating or alleviating staphylococcal nasal colonization using lysostaphin
08/14/2003WO2003065975A2 Processes for preparing crystalline and amorphous mupirocin calcium
08/14/2003WO2003065973A2 Multivalent streptococcal vaccine compositions and methods for use
08/14/2003WO2003065806A1 New immunoeffector compounds
08/14/2003WO2003047617A3 Vaccine
08/14/2003WO2003043647A3 A plant extract active as an immunostimulating agent
08/14/2003WO2003038032A8 Means for inhibition of the synthesis of viral proteins
08/14/2003WO2003037335A8 5-heteroatom-substituted pyrazoles
08/14/2003WO2003035177A3 Optimal polymer mixtures for gastric retentive tablets
08/14/2003WO2003033499A3 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
08/14/2003WO2003032973A3 Composition comprising paracetamol and a bitterness masking component
08/14/2003WO2003032898A3 Modified human thymic stromal lymphopoietin
08/14/2003WO2003029433A3 Chimeric viral vectors for gene therapy
08/14/2003WO2003017935A3 Human antibodies specific for interleukin 15 (il-15)
08/14/2003WO2003002069A3 Intradermal delivery of vaccines and gene therapeutic agents via microcannula
08/14/2003WO2002101048A3 NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-7 GENE
08/14/2003WO2002099108A3 Atp-binding cassette transporter-like molecules and uses thereof
08/14/2003WO2002074336A3 Influenza vaccine formulations for intradermal delivery
08/14/2003WO2002070653A3 Peptide deformylase inhibitors
08/14/2003WO2002064083A3 Synthesis of 3-amino-thalidomide and its enantiomers
08/14/2003WO2002059154A9 Neutralizing human monoclonal antibodies against hiv-1, their production and uses
1 ... 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 ... 1798